NC3Rs

What NC3Rs does

NC3Rs (National Centre for the Replacement, Refinement and Reduction of Animals in Research) is a UK-based, government-mandated scientific organisation founded in 2004 to promote the 3Rs across the life sciences research base. It is legally represented by the Medical Research Council (MRC), part of UK Research and Innovation (UKRI), but managed independently, with primary funding from the UK Government and supplementary co-funding from charitable organisations (notably the British Heart Foundation) and pharmaceutical companies (notably GSK and AstraZeneca). The organisation operates with 11-50 employees and is based in London, serving academic researchers, animal technicians, pharmaceutical/biotech companies, regulators, early-career researchers, and research funders and journals in the UK and internationally.

NC3Rs' core deliverables are scientific resources rather than commercial products. Its asset base includes the ARRIVE reporting guidelines (hosted at arriveguidelines.org), the free Experimental Design Assistant (EDA) online tool for reproducible experimental planning, the challenge-led CRACK IT Innovation Platform, and the open-access NC3Rs Gateway on F1000Research for publishing funded research outputs. Supporting instruments include the Tech3Rs and Tox News newsletters, a 3Rs resource library segmented by topic and audience, the Macaque Website for non-human primate welfare, and an annual 3Rs Prize co-funded with GSK, which has run for 18 years. Demand is generated almost entirely through free content, funding scheme calls (PhD studentships at £30k/year, project grants typically ranging £90k-£534k, public engagement awards up to £2k, and CRACK IT challenges), events including the NC3Rs/IAT Animal Technicians' Symposium, and webinars. Notable customer outcomes include a 2025 January multi-site £534,427 grant replacing in vivo arterial thrombosis models with human ex vivo placental artery platforms, and the 2019 Precision Injection System commercialised via Active Needle Technology Ltd following a CRACK IT challenge.

The operating model is non-profit grant-making and convening rather than commercial sales. The portfolio of strategic partnerships underpins revenue and impact: £1.08M co-funded with BHF across 12 PhD studentships, £2M deployed with Innovate UK (February 2026) for non-animal pharmacokinetic and cardiovascular safety approaches, over £200k with BBSRC for academic-industry network partnerships, an ABPI-National landscape review on UK pre-clinical model development, and a Defra/Concawe/Corteva-funded analysis on EU REACH endocrine disruptor assessment implications. Regulatory influence is material, with the UK Home Office adopting single-use needles as a 2019 themed inspection area following NC3Rs guidance.

Name

NC3Rs

Legal name

National Centre for the Replacement, Refinement and Reduction of Animals in Research

Website

https://nc3rs.org.uk

Company type

Private

Founded year

2004

Operating status

Operating

Headcount range

11–50 employees

Short description

NC3Rs is a UK Government-mandated, MRC/UKRI-administered scientific organisation that funds and develops tools, guidelines, and innovation platforms to replace, reduce, and refine the use of animals in research, serving academic researchers, animal technicians, pharmaceutical companies, and regulators globally with free resources.

Ownership category

akta.pro rank

Product category

Scientific Research Services for Animal Alternatives

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417), Other Scientific and Technical Consulting Services (541690)

SIC

Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Research Ethics & Human Subjects Protection Authorities (IRB/REC Oversight) (HLAJACAG)

Keywords

• Animal research alternatives
• 3Rs research funding
• Experimental design tools
• Scientific reporting guidelines
• Non-animal technologies

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Others

Revenue model

1. Government Funding: NC3Rs is primarily funded by the UK Government through its mandate to support the UK science base. Although represented legally by the Medical Research Council (MRC), which is part of UK Research and Innovation, NC3Rs is managed independently.
2. Charitable and Private Sector Co-funding: NC3Rs receives co-funding and support from charitable organizations (e.g., British Heart Foundation co-funding PhD studentships) and private sector partners (e.g., GSK co-funding the annual 3Rs Prize, AstraZeneca/GSK sponsoring CRACK IT Challenges).

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels11 records

Core offering

NC3Rs is a UK-based scientific organization that funds research, develops guidelines and online tools, and runs challenge-led competitions to help the life sciences community replace, reduce, and refine the use of animals in research. Its core offerings include the 3Rs Resource Library, ARRIVE reporting guidelines, the Experimental Design Assistant (EDA) software, the CRACK IT Innovation Platform, research grants and PhD studentships, and the annual 3Rs Prize.

Product overview

The NC3Rs offers a portfolio of interconnected scientific resources, tools and platforms focused on the 3Rs (Replacement, Refinement, and Reduction of animals in research). The core offerings include the 3Rs Resource Library providing guidelines and practical materials, the CRACK IT Innovation Platform for challenge-led funding competitions, the Experimental Design Assistant (EDA) for experiment planning, and the NC3Rs Gateway on F1000Research for publishing research outputs. Supporting products include the ARRIVE Guidelines for reporting standards, the Tech3Rs and Tox News newsletters for community updates, the dedicated Macaque Website, the annual 3Rs Prize for recognition of exceptional research, and innovations like the Precision Injection System developed through CRACK IT Challenges. These products work together to support researchers, technicians, and organizations in implementing 3Rs approaches across the life sciences.

Differentiator

Problem solved

Functional benefit

Brands

• CRACK IT: Innovation Platform - Challenge-led funding competition bringing together expertise from different sectors to deliver 3Rs models and tools that are more predictive and cost-effective than current animal models.
• ARRIVE guidelines
• Experimental Design Assistant (EDA)
• NC3Rs Gateway

Products and services

• ARRIVE Guidelines Internationally recognized guidelines for improving scientific reporting of animal research, designed to maximize the value of animal studies and reduce waste. Targeted at researchers, journals, funders, and institutions.
• Experimental Design Assistant (EDA) Free online tool that helps researchers design more reliable and reproducible experiments through computer-based logical reasoning and feedback in a drag-and-drop node interface.
• CRACK IT Innovation Platform Open innovation funding competition bringing together expertise from industry, academia, and SMEs to deliver readily available 3Rs models and tools that are more predictive and cost-effective than current animal models.
• 3Rs Prize Annual international prize co-funded by GSK awarded for outstanding work that has or could have major impacts on the replacement, reduction, or refinement of animal use in research; includes a £28k prize grant and £2k personal award to the winner.
• NC3Rs Funding Schemes (Project Grants, PhD Studentships, CRACK IT Challenges, Early Career and Public Engagement Awards) Competitive grant funding schemes including Project Grants (e.g., £198,933, £534,427 awards), NC3Rs/BHF co-funded PhD Studentships (£30k per annum for 3 years), Public Engagement Awards (up to £2k), and early career awards; awarded through two-stage peer review.
• 3Rs Resource Library Comprehensive collection of guidelines, practical information, publications, video, and training materials covering alternatives, experimental design, genetic modification, handling, husbandry, in vivo techniques, new approach methodologies, research culture, toxicology, and welfare assessment.
• NC3Rs Gateway on F1000Research Open access publication platform for NC3Rs grant holders to publish detailed methodology, performance characteristics, and validation data for 3Rs tools and technologies.
• Tech3Rs Newsletter Regular newsletter providing animal technicians with the latest news on 3Rs advances, new resources, research, and events relevant to animal facilities; translated into French and German editions.
• Tox News Newsletter Quarterly e-newsletter keeping the scientific community updated on news from the NC3Rs Toxicology and Regulatory Sciences programme, including events, publications, funding opportunities, and CRACK IT Challenges.
• The Macaque Website Dedicated resource website focused on macaque welfare and best practices in non-human primate research.
• Precision Injection System Technology developed through the Sharp and to the Point CRACK IT Challenge that encourages single-use of sterile needles, reduces injection time in large cohorts, and minimizes dead space within syringes to improve animal welfare in rodent preclinical injections.

Quantifiable outcome

• Over 700 mice replaced in a single lab through ex vivo aneurysm model; potential to replace ~4,500 mice/year across aneurysm research
• +8 more outcomes

Named customers14 records

Segments7 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

Ten partnerships are on record, tiered core and minor.

• Association of the British Pharmaceutical Industry (ABPI)coreStrategic or Co-development Partner · 1 February 2026NC3Rs collaborated with ABPI to produce a landscape review of human-relevant pre-clinical model development in the UK. The report examines the UK academic ecosystem for in vitro models and evaluates their readiness for pharmaceutical industry adoption, identifying significant gaps and £60M of UK Government investment opportunities.
• Only Good Antibodies (OGA) CommunityminorStrategic or Co-development Partner · 1 April 2025NC3Rs recruited 16 Antibody Champions in partnership with the Only Good Antibodies (OGA) community. These researchers will drive validation and use of better (non-animal or validated) antibodies across UK institutions.
• Health and Environmental Sciences Institute (HESI)coreStrategic or Co-development Partner · 1 January 2020NC3Rs co-hosted an expert workshop with HESI in 2020 on investigating endocrine-disrupting properties of chemicals in fish and amphibians. NC3Rs leads multiple projects in collaboration with HESI and expert working groups to apply the 3Rs in aquatic endocrine disruptor testing, including reviewing fish vitellogenin assessment, amphibian metamorphosis assays, and medaka extended one generation reproduction tests.
• European Partnership for Alternative Approaches to Animal Testing (EPAA)coreStrategic or Co-development PartnerNC3Rs was involved in an EPAA-funded project including 14 pharmaceutical companies and the Netherlands Medicines Evaluation Board to evaluate whether 6-month toxicity studies are necessary to assess long-term safety of monoclonal antibodies. This led to a weight-of-evidence model for when 3-month studies are sufficient.
• AstraZenecacoreGTM or Marketing PartnerAstraZeneca is a sponsor of the Sharp and to the Point CRACK IT Challenge alongside GSK and University of Sheffield. AstraZeneca has also implemented NC3Rs guidelines such as single-use of needles as a refinement across their sites, with Dr Sally Robinson actively promoting these practices through NC3Rs blog posts and webinars.
• University of SheffieldcoreGTM or Marketing PartnerCo-sponsor of the Sharp and to the Point CRACK IT Challenge alongside GSK and AstraZeneca. Dr Lucy Whitfield from University of Sheffield served as a Challenge Sponsor for the development of the Precision Injection System.
• Swiss 3R Competence Centre (3RCC)minorStrategic or Co-development PartnerSwiss 3R Competence Centre coordinates French and German translations of the Tech3Rs newsletter (from issue 15 onward) alongside FC3R and Charite 3R, enabling increased reach of technician resources across Europe.
• FC3R (French 3R Centre)minorStrategic or Co-development PartnerFC3R produces French translations of the Tech3Rs newsletter from issue 15 onward, enabling French-speaking animal technicians to access NC3Rs resources.
• Charite 3RminorStrategic or Co-development PartnerCharite 3R produces German translations of the Tech3Rs newsletter from issue 15 onward, enabling German-speaking animal technicians to access NC3Rs resources.
• 14 Pharmaceutical Companies (IQ DruSafe/NHP Reuse Working Group, BioSafe, EFPIA)coreStrategic or Co-development PartnerNC3Rs collaborates with international pharmaceutical company consortia including IQ DruSafe NHP Reuse Working Group, BioSafe, and EFPIA on projects to minimize non-human primate use in drug development, including the EPAA project on monoclonal antibody toxicity studies.

Scale indicators14 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Johns Hopkins Center for Alternatives to Animal Testing (CAAT): CAAT is an academic centre at Johns Hopkins Bloomberg School of Public Health focused on advancing alternatives to animal testing in toxicology. It is a direct peer to NC3Rs as both fund and develop alternatives, drive regulatory science, and run community outreach programs (CAAT hosts the annual ACT conference; NC3Rs runs the 3Rs Prize).
• EU Reference Laboratory for Alternatives to Animal Testing (EURL ECVAM): EURL ECVAM is the European Commission's validation body for alternative methods and OECD test guideline development. It is a direct peer to NC3Rs as both engage regulatory authorities, validate NAMs for regulatory acceptance, and shape OECD test guidelines — though EURL ECVAM operates at EU level rather than UK.
• InterNICHE: InterNICHE is an international network for humane education and the development and dissemination of alternatives to animal use in biomedical and life-science education and training. It is a direct peer to NC3Rs as both fund and promote alternatives globally, though InterNICHE focuses on education/training whereas NC3Rs is broader across the research lifecycle.
• Swiss 3R Competence Centre (3RCC): The Swiss national 3R centre with an analogous mandate to drive Replacement, Reduction and Refinement of animal use in research. It is a direct peer to NC3Rs as both are government-backed national bodies funding 3Rs grants, coordinating international networks, and partnering on Tech3Rs newsletter translations.
• FC3R (French Centre for the 3Rs): FC3R is the French national 3R centre coordinating French-language 3Rs efforts. It is a direct peer to NC3Rs as both serve national 3Rs mandates, fund French-language outreach (FC3R translates Tech3Rs), and collaborate on international 3Rs promotion.
• PETA International Science Consortium Ltd. PISC funds and conducts scientific research to replace animal use in toxicology testing, with a similar challenge-led funding model and emphasis on regulatory acceptance of NAMs. It is a direct peer to NC3Rs because both fund 3Rs research outputs and influence FDA, OECD, and pharma testing protocols.
• Danish 3R-Center: The Danish 3R-Center is the Danish national 3R research centre under the Danish Ministry of Food, Agriculture and Fisheries. It is a direct peer to NC3Rs because both are publicly funded national bodies that fund 3Rs research, promote alternative methods, and engage regulatory bodies across Europe.
• Charité 3R: Charité 3R is the German national 3R research centre based at Charité University Medicine Berlin. It is a direct peer to NC3Rs as both are academic/government-backed 3Rs hubs funding NAMs projects, training, and resources — and Charité 3R is already a close partner, co-publishing the German Tech3Rs newsletter.
• Norecopa: Norecopa is Norway's national platform for the 3Rs, coordinated by the Norwegian Veterinary Institute. It is a direct peer to NC3Rs as both consolidate 3Rs resources, guidelines, and harmonisation efforts nationally and internationally, and serve as information hubs for researchers, technicians, and regulators.
• European Partnership for Alternative Approaches to Animal Testing (EPAA): EPAA is a public-private partnership between the European Commission, industry, and academia promoting the 3Rs across sectors. It is a direct peer to NC3Rs because both focus on driving development and regulatory acceptance of NAMs, coordinate pharma consortia, and run challenge-led 3Rs work (NC3Rs has co-led EPAA-funded projects like the 6-month toxicity monoclonal antibody study).

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/NC3Rs
• YouTubeyoutube.com/user/NC3Rs1
• Facebookfacebook.com/NC3Rs
• LinkedInlinkedin.com/company/national-centre-3rs

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NC3Rs